
浏览全部资源
扫码关注微信
纸质出版日期:2012
移动端阅览
林海燕, 赵岩, 于佳宁, 等. 萎胃康治疗慢性萎缩性胃炎的拆方研究[J]. 中国实验方剂学杂志, 2012,18(3):139-142.
LIN Hai-yan, ZHAO Yan, YU Jia-ning, et al. The Study of Weiweikang Treating Chronic Atrophic Gastritis and Analysis of the Prescription[J]. Chinese journal of experimental traditional medical formulae, 2012, 18(3): 139-142.
林海燕, 赵岩, 于佳宁, 等. 萎胃康治疗慢性萎缩性胃炎的拆方研究[J]. 中国实验方剂学杂志, 2012,18(3):139-142. DOI: CNKI:11-3495/R.20111202.1024.003.
LIN Hai-yan, ZHAO Yan, YU Jia-ning, et al. The Study of Weiweikang Treating Chronic Atrophic Gastritis and Analysis of the Prescription[J]. Chinese journal of experimental traditional medical formulae, 2012, 18(3): 139-142. DOI: CNKI:11-3495/R.20111202.1024.003.
目的: 探讨萎胃康及其拆方对慢性萎缩性胃炎(CAG)模型大鼠的治疗作用。方法: 将70只Wistar大鼠随机抽取12只为正常对照组(正常组)
其余58只采用多重刺激6周复制大鼠CAG模型。确定造模成功的50只随机分为5组
即模型组、萎胃康全方组(全方组)、拆方Ⅰ号组(补益组)、拆方Ⅱ号组(祛邪组)、维霉素对照组(西药组)
分别ig 0.9%生理盐水(10 mL ·kg-1)、萎胃康水煎液(8 g ·kg-1)、拆方Ⅰ号水煎液(5.5 g ·kg-1)、拆方Ⅱ号水煎液(2.5 g ·kg-1)和维霉素混悬液(0.3 g ·kg-1)
1次/日。给药30 d后
观察对大鼠胃黏膜组织形态及血清超氧化物歧化酶(SOD)活力和丙二醛(MDA)含量的影响。结果: 全方组大鼠胃黏膜组织接近正常组。与正常组SOD(239.88±6.32)U ·mL-1
MDA(3.17±0.02)μmol ·L-1比较
模型组SOD(174.59±12.81)U ·mL-1明显降低(P<0.01)
MDA(5.14±0.15)μmol ·L-1明显升高(P<0.01)。与模型组比较
各用药组大鼠血清SOD明显升高
MDA 显著降低(P<0.01或P<0.05);与全方组SOD(233.91±9.03)U ·mL-1
MDA(3.11±0.19)μmol ·L-1比较
补益组、祛邪组大鼠血清SOD明显降低
MDA 显著升高;与补益组SOD(221.58±5.71)U ·mL-1比较
祛邪组大鼠血清SOD(209.89 ±5.27) U ·mL-1活力明显降低(P<0.05)。结论: 萎胃康能改善和逆转实验性萎缩性胃炎大鼠胃黏膜萎缩。其中益气养阴药物起主要作用
祛邪药物起协同作用
其机制可能与抗自由基损伤有关。
Objective:To study function of Weiweikang on treating chronic atrophic gastritis (CAG) model rats. Method: Twelve rats were randomly selected from 70 Wistar rats as normal control group (normal group).The remaining 58 rats were made CAG model with the multiple stimulations for 6 weeks. The remaining 50 rats which were modelede successfully were randomly divided into five groups such as model group
Weiweikang whole formula group (the whole formula group)
split part Ⅰ group (buyi group)
split part Ⅱ group (quxie group)and western medicine control group (western medicine group). The rats in every groups were ig 0.9% saline (0.09 g · kg-1)
Weiweikang decoction (8 g · kg-1)
split part I decoction (5.5 g · kg-1)
split part Ⅱ decoction (2.5 g · kg-1) and the neomycin-dimensional suspension (0.3 g · kg-1)
once a day
respectively.After 90 days of treatment
the gastric mucosa pathological changes were observed
the changes of superoxide dismutas(SOD)and malonyl dialdehyd(MDA)content in blood serum were detect. Result: There was no marked difference in the different-iation of gastric mucosa pathematology and microanatomy between the whole formula group and the normal group. Compared with normal control group whose SOD is (239.88±6.32) U ·mL-1and MDA is (3.17±0.02) μmol ·L-1
SOD of model group with (174.59±12.81) U ·mL-1decrease significantly(P<0.01) and MDA of model group with (5.14±0.15) μmol ·L-1 increase significantly(P<0.01). Compared with model group
the other medication groups made a significant increase of SOD and made the level of MDA decrease significantly(P<0.01 or P<0.05);Compared with model group with SOD (174.59±12.81) U ·mL-1
MDA (5.14±0.15) μmol · L-1
the other medication groups made a significant increase of SOD and the level of MDA decrease significantly(P<0.01 or P<0.05);Compared with the whole formula group with SOD (233.91±9.03) U ·mL-1
MDA: (3.11±0.19) μmol ·L-1
the buyi group and quxie group made a significant decrease of SOD and made the level of MDA increase significantly (P<0.01 or P<0.05);Compared with the buyi group with SOD (221.58±5.71) U ·mL-1
the activity of SOD with (209.89±5.27) U ·mL-1 in serum was significantly lower in quxie group rats (P<0.05). Conclusion: Weiweikang can improve and reverse the gastric atrophy of experimental atrophic gastritis of rats
among which ingredinets with benefiting QI and nourishing YIN founctios play a major role and ingredients with expelling pathogen plays synergy action.Its mechanism may be related to scavenging resisting the free radicals.
0
浏览量
3
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621